FTE Reimbursement Clause Samples
The FTE Reimbursement clause defines the terms under which a party is compensated for the time and effort of its employees, measured in Full-Time Equivalents (FTEs), dedicated to a project or service. Typically, this clause outlines how FTE hours are tracked, the applicable reimbursement rates, and any limits or reporting requirements associated with such payments. For example, it may specify that the service provider will be reimbursed monthly based on the number of FTEs assigned to the client’s project, with detailed timesheets as supporting documentation. The core function of this clause is to ensure transparent and fair compensation for labor resources, preventing disputes over staffing costs and clarifying financial obligations between the parties.
FTE Reimbursement. During the applicable Research Term, Pfizer shall reimburse CytomX for the costs of CytomX FTEs incurred in performing its Research Plan Activities at the FTE Rate. Pfizer shall be obligated to reimburse CytomX for [***] FTEs in aggregate per Calendar Year. Subject to the foregoing, the JRC shall determine the specific number of FTEs that shall perform Research Plan Activities for CytomX from time to time. By [***] of the applicable Research Term, the JRC shall estimate the number of projected CytomX FTE’s to be utilized in the subsequent [***] period of such Research Term, provided that the JRC shall evaluate and revise, as applicable, such estimate at each Calendar Quarterly meeting for the following Calendar Quarter, provided, further, that the JRC shall not reduce the number of FTEs set forth in such estimate unless Pfizer has provided CytomX with [***]’ advanced written notice of its intention to reduce such number from the most recent annual estimate. Notwithstanding the foregoing, Pfizer shall only be obligated to reimburse CytomX for the number of FTEs actually incurred and reported pursuant to Section 5.3.3 in the performance of its Research Plan Activities.
FTE Reimbursement. During the term of this Agreement, GenQuest shall reimburse Corixa for each full-time equivalent ("FTE") as set forth in Schedule A. The amount of such Reimbursable Costs shall be as set forth on Schedule A. It is understood that, except as provided in Section 3.2 below and Exhibit A hereto, the Reimbursable Costs to be paid under this Section 3.1 include all costs to be reimbursed to Corixa with respect to Corixa's performance of services pursuant to this Agreement, and such payments shall be used solely for the purposes of performing such services.
FTE Reimbursement. During the Research Term, Pfizer shall reimburse MacroGenics for the costs of the FTEs for the Research Program at the FTE Rate per FTE per Calendar Year. ***
FTE Reimbursement. PRI shall pay to Dendreon the sum of [ * ] US Dollars [ * ] for each FTE provided for in the Collaboration Research Plan. PRI shall pay to Dendreon [ * ] US Dollars [ * ] within [ * ] days after the Effective Date for FTE reimbursement for the period [ * ] through [ * ]. Thereafter, FTE reimbursement payments shall be made within [ * ] days after receipt of respective quarterly invoices rendered by Dendreon to PRI.
FTE Reimbursement. During the Research Term, GenQuest shall pay Corixa the amounts set forth on Schedule 3.2 hereto; provided, however, that the parties agree that in no event shall the amount paid to Corixa per quarter to Corixa be less than such amounts without Corixa's prior written consent, provided that Corixa has applied to the Research at least the number of FTEs set forth in Schedule 3.2. It is understood that, except as provided in Section 8.2 below, the FTE costs to be paid under this Section 8.1 include all costs to be reimbursed to Corixa with respect to Corixa's performance of its responsibilities under the Research Plan.